Iguratimod

• Description:

  A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-κB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBα degradation.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  374.3679

• Molecular Formula:

  C17H14N2O6S

• Notes:

  Research use only, not for human use.

• Receptor:

  COX-2|MIF

• CAS Number:

  123663-49-0